rs464691
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_144672.4(OTOA):āc.2417A>Cā(p.Tyr806Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000348 in 1,613,148 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_144672.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOA | NM_144672.4 | c.2417A>C | p.Tyr806Ser | missense_variant | 22/29 | ENST00000646100.2 | NP_653273.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOA | ENST00000646100.2 | c.2417A>C | p.Tyr806Ser | missense_variant | 22/29 | NM_144672.4 | ENSP00000496564.2 |
Frequencies
GnomAD3 genomes AF: 0.00128 AC: 194AN: 151960Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000422 AC: 106AN: 250996Hom.: 0 AF XY: 0.000398 AC XY: 54AN XY: 135638
GnomAD4 exome AF: 0.000252 AC: 368AN: 1461070Hom.: 2 Cov.: 32 AF XY: 0.000245 AC XY: 178AN XY: 726818
GnomAD4 genome AF: 0.00127 AC: 193AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.00118 AC XY: 88AN XY: 74364
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 12, 2018 | - - |
OTOA-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 25, 2024 | The OTOA c.2417A>C variant is predicted to result in the amino acid substitution p.Tyr806Ser. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.35% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 08, 2015 | p.Tyr806Ser in exon 21 of OTOA: This variant is not expected to have clinical s ignificance because the tyrosine (Tyr) residue at position 806 is not conserved through species, with >10 mammals having a serine (Ser) at this position. It has been identified in 0.4% (41/10356) of African chromosomes by the Exome Aggregat ion Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs464691). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at